The global corticosteroids market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. Rising demand for topical and inhaled corticosteroids is primarily encouraging the growth of the market. Increasing prevalence of skin allergies and acute respiratory disorders has significantly increased the adoption of topical and inhaled corticosteroids. In 2018, the number of children under age 18 years with reported skin allergies in the US was 9.2 million, which is 12.6% of children under age 18 years. This leads to the increasing adoption of topical corticosteroids that are used for the treatment of skin problems, including dermatitis, rash, itching, eczema, and psoriasis.
(Get 15% Discount on Buying this Report)
A full report of Corticosteroids Market is available at: https://www.omrglobal.com/industry-reports/corticosteroids-market
Topical corticosteroids contain potent anti-inflammatory properties and acts to suppress the immune response. These corticosteroids are utilized based on the area of the body where it will be applied, their effectiveness, and kind of skin problem being treated. Topical corticosteroids are available in the form of cream, ointment, gel, and lotion. Based on the potency, the topical corticosteroids are classified into very high potency, high potency, medium potency and low potency corticosteroids. Topical corticosteroids are significantly used to treat inflammatory skin conditions, including contact dermatitis, atopic eczema, and psoriasis. These corticosteroids are used to relieve symptoms and suppress signs of the disorder, including redness, swelling, and itching. Some topical corticosteroids include fluocinonide (Vanos), alclometasone dipropionate (Aclovate), betamethasone valerate (Luxiq), and desonide (Desowen, Verdeso).
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/corticosteroids-market
Increasing prevalence of acute respiratory disorders, including asthma and COPD, has led the demand for inhaled corticosteroids. As per the World Health Organization (WHO), in 2016, over 339 million people were suffering from asthma across the globe and is a common condition among children. In 2016, nearly 251 million people were suffering from COPD across the globe. There are several medications available for the management of asthma medications.
Inhaled corticosteroids are the most commonly used anti-inflammatory medications which are successfully used for the management of asthma for more than 50 years. Such asthma medications decrease several types of airway inflammations, which enables to normalize the production of mucus, swelling and tightening of bronchial tubes, and airway hypersensitivity. These medications can prevent the patient from having an asthma flare-up or prevent worsening of symptoms. Some instances of inhaled corticosteroids include ciclesonide, beclomethasone, triamcinolone, fluticasone, budesonide, and flunisolide.
Global Corticosteroids Market- Segmentation
By Product
- Glucocorticoids
- Mineralocorticoids
By Route of Administration
- Topical
- Inhaled
- Oral
- Systemic
- Others
By Application
- Skin Allergies
- Rheumatology Indications
- Endocrinology
- Acute Respiratory Diseases
- Gastroenterology
- Others
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
